It should be easier for GPs to work out the cheapest drug options
IMPROVING PRACTICE SOFTWARE
THE continuing removal of medicines from the Pharmaceutical Benefits Scheme (PBS), concurrent with increasing patient co-payments for those medicines that remain on the PBS, makes it cheaper per dose for some patients to buy their medicines on a private prescription.
This is especially true if they buy larger quantities than the PBS will allow.
Limitations on the quantities of some Schedule 2 and 3 medicines sold over the counter mean that, for some products, it is cheaper per dose for the patient to